Annual Shareholders Equity
$30.04 M
-$27.11 M-47.44%
01 June 2022
Summary:
Pluristem Therapeutics annual stockholders equity is currently $30.04 million, with the most recent change of -$27.11 million (-47.44%) on 01 June 2022. During the last 3 years, it has fallen by -$27.11 million (-47.44%).PSTI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$24.19 M
-$5.85 M-19.46%
01 September 2022
Summary:
Pluristem Therapeutics quarterly stockholders equity is currently $24.19 million, with the most recent change of -$5.85 million (-19.46%) on 01 September 2022.PSTI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | -47.4% | -50.5% |
5 y5 years | +37.7% | +38.0% |
PSTI Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -51.6% | -66.5% |
Pluristem Therapeutics Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $24.19 M(-19.5%) |
June 2022 | $30.04 M(-47.4%) | $30.04 M(-21.1%) |
Mar 2022 | - | $38.09 M(-4.4%) |
Dec 2021 | - | $39.84 M(-18.5%) |
Sept 2021 | - | $48.91 M(-14.4%) |
June 2021 | $57.15 M(+1.9%) | $57.15 M(-16.1%) |
Mar 2021 | - | $68.14 M(+65.6%) |
Dec 2020 | - | $41.15 M(-15.9%) |
Sept 2020 | - | $48.95 M(-12.8%) |
June 2020 | $56.10 M(+157.1%) | $56.10 M(+295.9%) |
Mar 2020 | - | $14.17 M(-10.9%) |
Dec 2019 | - | $15.91 M(-9.2%) |
Sept 2019 | - | $17.53 M(-19.7%) |
June 2019 | $21.82 M(-23.5%) | $21.82 M(+152.9%) |
Mar 2019 | - | $8.63 M(-43.2%) |
Dec 2018 | - | $15.19 M(-29.4%) |
Sept 2018 | - | $21.53 M(-24.5%) |
June 2018 | $28.51 M(-5.8%) | $28.51 M(-14.2%) |
Mar 2018 | - | $33.23 M(-10.1%) |
Dec 2017 | - | $36.96 M(+51.7%) |
Sept 2017 | - | $24.36 M(-19.5%) |
June 2017 | $30.25 M(-20.7%) | $30.25 M(-15.1%) |
Mar 2017 | - | $35.62 M(+41.8%) |
Dec 2016 | - | $25.11 M(-23.7%) |
Sept 2016 | - | $32.90 M(-13.8%) |
June 2016 | $38.16 M(-34.4%) | $38.16 M(-11.5%) |
Mar 2016 | - | $43.11 M(-12.7%) |
Dec 2015 | - | $49.35 M(-5.7%) |
Sept 2015 | - | $52.35 M(-10.0%) |
June 2015 | $58.14 M(-6.4%) | $58.14 M(+27.6%) |
Mar 2015 | - | $45.55 M(-7.3%) |
Dec 2014 | - | $49.14 M(-8.5%) |
Sept 2014 | - | $53.70 M(-13.6%) |
June 2014 | $62.12 M(+8.1%) | $62.12 M(-5.8%) |
Mar 2014 | - | $65.96 M(+8.4%) |
Dec 2013 | - | $60.83 M(+11.0%) |
Sept 2013 | - | $54.79 M(-4.7%) |
June 2013 | $57.47 M(+52.3%) | $57.47 M(-10.2%) |
Mar 2013 | - | $64.02 M(-7.3%) |
Dec 2012 | - | $69.04 M(-4.4%) |
Sept 2012 | - | $72.19 M(+91.3%) |
Date | Annual | Quarterly |
---|---|---|
June 2012 | $37.74 M(-13.1%) | $37.74 M(-0.4%) |
Mar 2012 | - | $37.90 M(-6.1%) |
Dec 2011 | - | $40.35 M(+0.1%) |
Sept 2011 | - | $40.29 M(-7.2%) |
June 2011 | $43.42 M(+990.7%) | $43.42 M(-5.1%) |
Mar 2011 | - | $45.74 M(+664.6%) |
Dec 2010 | - | $5.98 M(+119.0%) |
Sept 2010 | - | $2.73 M(-31.4%) |
June 2010 | $3.98 M(+17.3%) | $3.98 M(+51.5%) |
Mar 2010 | - | $2.63 M(-40.1%) |
Dec 2009 | - | $4.38 M(+42.8%) |
Sept 2009 | - | $3.07 M(-9.5%) |
June 2009 | $3.39 M(+45.7%) | $3.39 M(+11.0%) |
Mar 2009 | - | $3.06 M(-8.3%) |
Dec 2008 | - | $3.33 M(+6.6%) |
Sept 2008 | - | $3.13 M(+34.3%) |
June 2008 | $2.33 M(-60.5%) | $2.33 M(-43.6%) |
Mar 2008 | - | $4.13 M(-22.5%) |
Dec 2007 | - | $5.33 M(-3.7%) |
Sept 2007 | - | $5.54 M(-6.1%) |
June 2007 | $5.90 M(-1015.4%) | $5.90 M(+120.9%) |
Mar 2007 | - | $2.67 M(+309.3%) |
Dec 2006 | - | $652.20 K(-224.2%) |
Sept 2006 | - | -$525.30 K(-18.5%) |
June 2006 | -$644.20 K(-135.7%) | -$644.20 K(-278.2%) |
Mar 2006 | - | $361.60 K(-61.6%) |
Dec 2005 | - | $942.00 K(-35.2%) |
Sept 2005 | - | $1.45 M(-19.3%) |
June 2005 | $1.80 M(+405.1%) | $1.80 M(+49.5%) |
Mar 2005 | - | $1.21 M(+1160.3%) |
Dec 2004 | - | $95.70 K(-9.5%) |
Sept 2004 | - | $105.80 K(-70.4%) |
June 2004 | $357.00 K(-27.2%) | $357.00 K(+291.4%) |
Mar 2004 | - | $91.20 K(-8.4%) |
Dec 2003 | - | $99.60 K(-78.8%) |
Sept 2003 | - | $470.30 K(-4.1%) |
June 2003 | $490.40 K(-750.4%) | $490.40 K(-2023.1%) |
Mar 2003 | - | -$25.50 K(+37.1%) |
Dec 2002 | - | -$18.60 K(-450.9%) |
Sept 2002 | - | $5300.00(-107.0%) |
June 2002 | -$75.40 K | -$75.40 K |
FAQ
- What is Pluristem Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Pluristem Therapeutics?
What is Pluristem Therapeutics annual stockholders equity?
The current annual shareholders equity of PSTI is $30.04 M
What is the all time high annual shareholders equity for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual stockholders equity is $62.12 M
What is Pluristem Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of PSTI is $24.19 M
What is the all time high quarterly shareholders equity for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly stockholders equity is $72.19 M